Sun Pharmaceutical Industries is currently trading at Rs. 579.50, up by 4.10 points or 0.71% from its previous closing of Rs. 575.40 on the BSE.
The scrip opened at Rs. 580.00 and has touched a high and low of Rs. 583.00 and Rs. 577.00 respectively. So far 99699 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 653.10 on 03-Mar-2014 and a 52 week low of Rs. 423.18 on 10-Apr-2013.
Last one week high and low of the scrip stood at Rs. 583.00 and Rs. 556.50 respectively. The current market cap of the company is Rs. 119630.43 crore.
The promoters holding in the company stood at 63.65% while Institutions and Non-Institutions held 28.23% and 8.11% respectively.
Sun Pharmaceutical is reportedly planning to purchase Standard Chartered Tower located at Goregaon suburb in Mumbai from Standard Chartered Bank for Rs 280 crore. Standard Chartered Tower has total built-up space of 2.20 lakh sq ft, with ground plus six upper floors including two basements. The deal is valued at Rs 12,700 per sq ft on a built-up space basis.
Both the parties have already entered into an agreement for transfer of the property .The deal will be concluded in the next few weeks.
Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: